Why has clinical evidence on IVF 'add-ons' not been forthcoming? A recent BBC Panorama programme investigated the use of these unproven add-ons – throughout the documentary there were repeated pleas for an evidence base for these treatments. Our experiences may shed light on why such evidence has not emerged.
Plastics that do not contain bisphenol A (BPA) – a compound known to harm reproductive health – may not necessarily be any safer than those that do, experiments in mice have shown.
The age at which a woman freezes her eggs has a significant impact on IVF success when they are thawed, suggests a new report by the UK's fertility regulator.
A study looking at whether frozen or fresh embryo transfers yield the best outcomes for IVF patients has found that the best technique varies from person to person, depending on their cycle so far.
The Human Fertilisation and Embryology Authority has today launched the first ever National Fertility Patient Survey. The objective is to give the UK's fertility patients an unprecedented chance to have their say.
A new approach to treating Marfan syndrome may be on the horizon, thanks to developments in genome editing.
Bulging biceps might make men more likely to appeal to the opposite sex, but extra muscle may take its toll on their sperm count.
WELCOME TO FIRST INTERNATIONAL CONGRESS FOR ASSISTED REPRODUCTIVE TECHNOLOGIES, FOCUS ON:OOCYTE. 27-28 OCTOBER WILL TAKE A PLACE IN KIEV,UKRAINE. 10 INTERNATIONAL AND 4 LOCAL WELL EXPERIENCED SPEAKER AND FRESH OOCYTE HANDS ON OOCYTE VITRIFICATION WORKSHOP. JOIN US. FOR THE REGISTRATION,
University of Mysore, MSc in Clinical Embryology & Pre-implantation Genetics Admission open for 2018 batch.
The recent Nuffield Council on Bioethics report 'Genome Editing and Human Reproduction: Social and Ethical Issues' has been both welcomed and criticised.
As is often the case with new reproductive technologies, some critics have raised concerns that new cases of conditions such as Down's syndrome could be eliminated by genome editing, and that the lives of existing people with this condition could be somehow devalued. Is there any factual basis for these concerns?